A Top Biotech CEO in Cancer Treatments: F-star Therapeutics CEO Eliot Forster

A Top Biotech CEO in Cancer Treatments: F-star Therapeutics CEO Eliot Forster

Eliot Forster is the Chief Executive Officer of F-star Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer. To date, the company has built a comprehensive IP estate, with over 200 issued patents and more than 60 pending applications, many of which have blockbuster potential.

In this conversation, we discuss Eliot’s career as a corporate executive in big pharma as well as his transition to and leadership experience in venture and growth stage biotech. Before coming to F-star in 2018, he served as chief executive officer of Immunocore and prior to that, he held executive positions at Creabilis Therapeutics, Solace Pharmaceuticals, and Pfizer.

We also explore the broader biotech industry in the context of private company investing as well as the specifics of F-star’s drug development programs.

We hope you enjoy the show

Episoder(253)

Software Growth Investor: Battery’s Satoshi Harris-Koizumi

Software Growth Investor: Battery’s Satoshi Harris-Koizumi

In this episode we speak with Satoshi Harris-Koizumi, Partner at Battery Ventures, a global, tech-focused investment firm with a track record spanning early, growth-equity, and buyout investments. Now...

23 Apr 202520min

Powering Specialty Lending: Octane’s Jason Guss

Powering Specialty Lending: Octane’s Jason Guss

In this episode, we speak with Jason Guss, Co-Founder and CEO of Octane, a financing platform assisting fast and confident powersports purchases by making financing as easy as cash and creating access...

9 Apr 202524min

Expansion-Stage Software Investor: Updata’s Jon Seeber

Expansion-Stage Software Investor: Updata’s Jon Seeber

In this episode we speak with Jon Seeber, General Partner of Updata Partners, a leading technology-focused growth equity firm based in Washington, D.C. Led by an investment team averaging more than 25...

26 Mar 202518min

Growth Equity Reimagined: Brighton Park Capital’s Mark Dzialga

Growth Equity Reimagined: Brighton Park Capital’s Mark Dzialga

In this episode we speak with Mark Dzialga, the Founder and Managing Partner of Brighton Park Capital, a growth equity investment firm focused on entrepreneur-led, growth-stage software, healthcare, a...

12 Mar 202520min

Software Savior: PAR Technologies’ Savneet Singh

Software Savior: PAR Technologies’ Savneet Singh

In this episode we speak with Savneet Singh, the President and CEO of PAR Technology, a global leader in restaurant technology. Since taking the helm, he has led PAR’s transformation from near bankrup...

5 Mar 202519min

Structured Equity Growth Investor: L2 Point’s Kerstin Dittmar

Structured Equity Growth Investor: L2 Point’s Kerstin Dittmar

In this episode we speak with Kerstin Dittmar, the Founder, Chief Investment Officer, and Managing Partner of L2 Point, a private investment firm focused on structured equity investments in growth com...

26 Feb 202524min

Private Credit Innovator: Monroe Capital’s Zia Uddin

Private Credit Innovator: Monroe Capital’s Zia Uddin

In this episode we speak with Zia Uddin, President of Monroe Capital, a premier asset management firm specializing in private credit markets across various strategies, including direct lending, techno...

19 Feb 202526min

Growth Equity Leader: Norwest’s Ran Ding

Growth Equity Leader: Norwest’s Ran Ding

In this episode we speak with Ran Ding, General Partner at Norwest, a global venture and growth equity investment firm managing more than $15.5 billion in capital. Since its inception, the firm has in...

12 Feb 202522min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengesnakk
utbytte
livet-pa-veien-med-jan-erik-larssen
tid-er-penger-en-podcast-med-peter-warren
finansredaksjonen
pengepodden-2
morgenkaffen-med-finansavisen
rss-sunn-okonomi
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
okonomiamatorene
lederpodden
liberal-halvtime
rss-politisk-preik